跳至主要内容
临床试验/ACTRN12619000406101
ACTRN12619000406101终止3 期

Evaluation of the efficacy of cysteamine cream compared to hydroquinone cream in the treatment of melasma: a randomised, double-blind, multi-centre trial.

Dr Michelle Rodrigues0 个研究点目标入组 20 人开始时间: 2019年3月13日最近更新:
适应症

试验速览

阶段
3 期
状态
终止
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • 1.Must provide informed consent
  • 2.Must be over the age of 18 and female
  • 3.Moderate to severe melasma defined by the following at screening visit:
  • a.Modified MASI scoring
  • 4.Melasma present for at least 3 months
  • 5.Willing and able to comply with study instructions and return to the study site for required visits
  • 6.Must be able to comply with the study regimen for the duration of the study.

排除标准

  • 1.Pregnant or breastfeeding
  • 2.Rashes on the face
  • 3.Job which is primarily outdoors (more than 2 hours per day) or goes to tanning salons
  • 4.Hydroquinone, or other bleaching agents, used within the last month
  • 5.Topical steroid applied to the face within the last month
  • 6.Retin A, retinol, tretinoin, Differin, or adapalene used within the last month
  • 7.Laser treatment to the face within the last month

研究者

发起方
Dr Michelle Rodrigues

相似试验